ARTICLE | Company News
BioVeris sales and marketing update
February 19, 2007 8:00 AM UTC
BIOV launched two products to detect the inflammatory cytokines IL-2 and TNF-alpha to measure potential immune responses to protein-based therapeutics. The company also launched a panel of six antibod...